|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu X, Zhou J, Zhou N, Zhu J, Feng Y and
Miao X: SYNJ2BP inhibits tumor growth and metastasis by activating
DLL4 pathway in hepatocellular carcinoma. J Exp Clin Cancer Res.
35:1152016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Han H, Wang L, Liu Y, Shi X, Zhang X, Li M
and Wang T: Combination of curcuma zedoary and kelp inhibits growth
and metastasis of liver cancer in vivo and in vitro via reducing
endogenous H2S levels. Food Funct. 10:224–234. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang X, Wang N, Cheung F, Lao L, Li C and
Feng Y: Chinese medicines for prevention and treatment of human
hepatocellular carcinoma: Current progress on pharmacological
actions and mechanisms. J Integr Med. 13:142–164. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu L, Cao KX, Ni ZH, Li WD, Chen ZP, Cheng
HB and Liu X: Effects of Dahuang zhechong pill on
doxorubicin-resistant SMMC-7721 ×enografts in mice. J
Ethnopharmacol. 222:71–78. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li W, Yan XT, Sun YN, Ngan TT, Shim SH and
Kim YH: Anti-Inflammatory and PPAR transactivational effects of
oleanane-type triterpenoid saponins from the roots of Pulsatilla
koreana. Biomol Ther (Seoul). 22:334–340. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu L, Gu L, Tao X, Xu Y, Qi Y, Yin L, Han
X and Peng J: Effect of dioscin on promoting liver regeneration via
activating Notch1/Jagged1 signal pathway. Phytomedicine.
38:107–117. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu Y, He K and Wang X: Role of Chinese
herbal medicinal ingredients in secretion of cytokines by
PCV2-induced endothelial cells. J Immunotoxicol. 13:141–147. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen Z, Duan H, Tong X, Hsu P, Han L,
Morris-Natschke SL, Yang S, Liu W and Lee KH: Cytotoxicity,
hemolytic toxicity, and mechanism of action of Pulsatilla Saponin D
and its synthetic derivatives. J Nat Prod. 81:465–474. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bang SC, Lee JH, Song GY, Kim DH, Yoon MY
and Ahn BZ: Antitumor activity of Pulsatilla koreana
saponins and their structure-activity relationship. Chem Pharm Bull
(Tokyo). 53:1451–1454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim Y, Bang SC, Lee JH and Ahn BZ:
Pulsatilla saponin D: The antitumor principle from Pulsatilla
koreana. Arch Pharm Res. 27:915–918. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wan JY, Zhang YZ, Yuan JB, Yang FQ, Chen
Y, Zhou LD and Zhang QH: Biotransformation and metabolic profile of
anemoside B4 with rat small and large intestine microflora by
ultra-performance liquid chromatography-quadrupole time-of-flight
tandem mass spectrometry. Biomed Chromatogr. 31:bmc.38732017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Bao J, Wang K, Jia X, Zhang C,
Huang B, Chen M, Wan JB, Su H, Wang Y and He C: Pulsatilla Saponin
D inhibits autophagic flux and synergistically enhances the
anticancer activity of chemotherapeutic agents against HeLa cells.
Am J Chin Med. 43:1657–1670. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Q, Chen W, Jiao Y, Hou J, Wu Q, Liu Y
and Qi X: Pulsatilla saponin A, an active molecule from
Pulsatilla chinensis, induces cancer cell death and inhibits
tumor growth in mouse xenograft models. J Surg Res. 188:387–395.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu L, Cheng G, Lu Y and Wang S: An active
molecule from Pulsatilla chinensis, Pulsatilla saponin A,
induces apoptosis and inhibits tumor growth of human colon cancer
cells without or with 5-FU. Oncol Lett. 13:3799–3802. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tong X, Han L, Duan H, Cui Y, Feng Y, Zhu
Y, Chen Z and Yang S: The derivatives of Pulsatilla saponin A, a
bioactive compound from Pulsatilla chinensis: Their
synthesis, cytotoxicity, haemolytic toxicity and mechanism of
action. Eur J Med Chem. 129:325–336. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang Q, Bermingham NA, Finegold MJ and
Zoghbi HY: Requirement of Math1 for secretory cell lineage
commitment in the mouse intestine. Science. 294:2155–2158. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu JN, Jiang L, Jiang JH, Yang X, Li XY,
Zeng JX, Shi RY, Shi Y, Pan XR, Han ZP and Wei LX: Hepatocyte
nuclear factor-1beta enhances the stemness of hepatocellular
carcinoma cells through activation of the Notch pathway. Sci Rep.
7:47932017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang T, Zhou Y, Cheng AS, Yu J, To KF and
Kang W: NOTCH receptors in gastric and other gastrointestinal
cancers: Oncogenes or tumor suppressors? Mol Cancer. 15:802016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takebe N, Miele L, Harris PJ, Jeong W,
Bando H, Kahn M, Yang SX and Ivy SP: Targeting Notch, Hedgehog, and
Wnt pathways in cancer stem cells: Clinical update. Nat Rev Clin
Oncol. 12:445–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Papayannidis C, DeAngelo DJ, Stock W,
Huang B, Shaik MN, Cesari R, Zheng X, Reynolds JM, English PA,
Ozeck M, et al: A Phase 1 study of the novel gamma-secretase
inhibitor PF-03084014 in patients with T-cell acute lymphoblastic
leukemia and T-cell lymphoblastic lymphoma. Blood Cancer J.
5:e3502015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hughes DP, Kummar S and Lazar AJ: New,
tolerable γ-secretase inhibitor takes desmoid down a notch. Clin
Cancer Res. 21:7–9. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li L, Tang P, Li S, Qin X, Yang H, Wu C
and Liu Y: Notch signaling pathway networks in cancer metastasis: A
new target for cancer therapy. Med Oncol. 34:1802017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu CX, Xu A, Zhang CC, Olson P, Chen L,
Lee TK, Cheung TT, Lo CM and Wang XQ: Notch inhibitor PF-03084014
inhibits hepatocellular carcinoma growth and metastasis via
suppression of cancer stemness due to reduced activation of
Notch1-Stat3. Mol Cancer Ther. 16:1531–1543. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhu PL, Fu XQ, Li JK, Tse AK, Guo H, Yin
CL, Chou JY, Wang YP, Liu YX, Chen YJ, et al: Antrodia camphorata
mycelia exert anti-liver cancer effects and inhibit STAT3 signaling
in vitro and in vivo. Front Pharmacol. 9:14492018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Y, Zhang C, Zhang S, Zhao Z, Wang J,
Song J, Wang Y, Liu J and Hou S: Kanglaite sensitizes colorectal
cancer cells to Taxol via NF-κΒ inhibition and connexin 43
upregulation. Sci Rep. 7:12802017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peng S, Yang K, Xu Z, Chen S and Ji Y:
Vincristine and sirolimus in the treatment of kaposiform
haemangioendothelioma. J Paediatr Child Health. 55:1119–1124. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu QM, Shu Z, He WJ, Chen LY, Yang SL,
Yang G, Liu YL and Li XR: Antitumor activity of Pulsatilla
chinensis (Bunge) Regel saponins in human liver tumor 7402
cells in vitro and in vivo. Phytomedicine. 19:293–300. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu AX, Finn RS, Edeline J, Cattan S,
Ogasawara S, Palmer D, Verslype C, Zagonel V, Fartoux L, Vogel A,
et al: Pembrolizumab in patients with advanced hepatocellular
carcinoma previously treated with sorafenib (KEYNOTE-224): A
non-randomised, open-label phase 2 trial. Lancet Oncol. 19:940–952.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
El-Khoueiry AB, Sangro B, Yau T, Crocenzi
TS, Kudo M, Hsu C, Kim TY, Choo SP, Trojan J, Welling TH Rd, et al:
Nivolumab in patients with advanced hepatocellular carcinoma
(CheckMate 040): An open-label, non-comparative, phase 1/2 dose
escalation and expansion trial. Lancet. 389:2492–2502. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He L, Zhang Y, Kang N, Wang Y, Zhang Z,
Zha Z, Yang S, Xu Q and Liu Y: Anemoside B4 attenuates
nephrotoxicity of cisplatin without reducing anti-tumor activity of
cisplatin. Phytomedicine. 56:136–146. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gong Q, He LL, Wang ML, Ouyang H, Gao HW,
Feng YL, Yang SL, Du LJ, Li J and Luo YY: Anemoside B4 protects rat
kidney from adenine-induced injury by attenuating inflammation and
fibrosis and enhancing podocin and nephrin expression. Evid Based
Complement Alternat Med. 2019:80310392019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Villanueva A, Alsinet C, Yanger K, Hoshida
Y, Zong Y, Toffanin S, Rodriguez-Carunchio L, Solé M, Thung S,
Stanger BZ and Llovet JM: Notch signaling is activated in human
hepatocellular carcinoma and induces tumor formation in mice.
Gastroenterology. 143:1660–1669.e7. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rizzo P, Mele D, Caliceti C, Pannella M,
Fortini C, Clementz AG, Morelli MB, Aquila G, Ameri P and Ferrari
R: The role of notch in the cardiovascular system: Potential
adverse effects of investigational notch inhibitors. Front Oncol.
4:3842015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Xue S, Zhou Y, Zhang J, Xiang Z, Liu Y,
Miao T, Liu G, Liu B, Liu X, Shen L, et al: Anemoside B4 exerts
anti-cancer effect by inducing apoptosis and autophagy through
inhibiton of PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Am
J Transl Res. 11:2580–2589. 2019.PubMed/NCBI
|
|
36
|
Zhang K, Hong X, Song Z, Xu Y, Li C, Wang
G, Zhang Y, Zhao X, Zhao Z, Zhao J, et al: Identification of
deleterious NOTCH mutation as novel predictor to efficacious
immunotherapy in NSCLC. Clin Cancer Res. 26:3649–3661. 2020.
View Article : Google Scholar : PubMed/NCBI
|
